Early-stage success increasingly depends on anticipating the full due diligence pathway, beyond clinical and technical validation. Reimbursement strategy, mapping payment systems and identifying funding alternatives are now key signals of investment readiness. How can TTOs better support their spin-offs as businesses in progress, not just science projects? And how can companies structure their roadmap narrative to facilitate acquisition or investment? Experts will share insights and best practices to align early strategies with potential partners’ expectations towards deal-making.
Due diligence pathways: Early-stage strategies
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 2:00 PM
- 2:45 PM
A toolbox session is designed to provide practical skills, easy-to-follow guidelines and take-home tools which delegates can put into practice to deal with their current issues.